SCHEMBL4149344

SCHEMBL4149344

CN(C(=O)c1c(F)cccc1Cl)C(=O)N(C)c1ccc(SC(F)(F)C(F)(F)C(F)(F)F)cc1F

nearest known ligand 0.43

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
RORC P51449 18/20 0.43
TLR7 Q9NYK1 2/20 0.41
RORA P35398 2/20 0.38
RORB Q92753 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4157262 0.93 ALDH1A1 (0.34) RORCTLR7RORARORB
SCHEMBL4162997 0.90 RORC (0.46) RORCTLR7RORARORB
SCHEMBL4158854 0.87 RORC (0.35) RORCTLR7RORARORB
SCHEMBL4141906 0.86 RORC (0.43) RORCTLR7RORARORB
SCHEMBL4668689 0.86 CYP11B1 (0.33) RORC
SCHEMBL4154565 0.86 RORC (0.41) RORCTLR7RORARORB
SCHEMBL4164252 0.85 RORC (0.40) RORCTLR7RORARORB
SCHEMBL4157914 0.84 RORC (0.48) RORCTLR7RORARORB
SCHEMBL4154057 0.83 TLR7 (0.40) RORCTLR7
SCHEMBL4154435 0.82 RORC (0.36) RORCTLR7RORARORB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
EP-1937629-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-07-02 EP disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 RORC 4448/4885TLR7 905/4885RORA 4206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.